RISANKIZUMAB INDUCTION THERAPY PROVIDES EARLY SYMPTOM IMPROVEMENTS IN ABDOMINAL PAIN AND STOOL FREQUENCY IN PATIENTS WITH MODERATE TO SEVERE CROHN’S DISEASE: RESULTS FROM TWO PHASE 3 INDUCTION STUDIES

Jean-Frédéric Colombel  1     Stefan Schreiber  2     Geert R. D'Haens  3     Joanne Rizzo  4     Kristina Kligys  4     Jenny Griffith  4     Javier Zambrano  4     Qian Zhou  4     Jasmina Kalabic  5     Florian Rieder  6     Marla C. Dubinsky  1     Remo Panaccione  7    
1 Icahn School of Medicine at Mount Sinai, New York, United States
2 University Hospital Schleswig-Holstein, Kiel University, Kiel, Germany
3 Amsterdam University Medical Center, Amsterdam, Netherlands
4 AbbVie Inc., North Chicago, United States
5 AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany
6 Cleveland Clinic, Cleveland, United States
7 University of Calgary, Calgary, Canada

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing